168 related articles for article (PubMed ID: 37923826)
1. Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.
Petrisor DC; Etropolska Z; Elenski K; Dimitrova E; Santos J
Dig Dis Sci; 2024 Jan; 69(1):161-168. PubMed ID: 37923826
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model.
Scuderi SA; Casili G; Lanza M; Ardizzone A; Pantaleo L; Campolo M; Paterniti I; Cucinotta L; Cuzzocrea S; Esposito E
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216383
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical study.
Burta O; Iacobescu C; Mateescu RB; Nicolaie T; Tiuca N; Pop CS
Transl Gastroenterol Hepatol; 2018; 3():72. PubMed ID: 30511026
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial.
Trifan A; Burta O; Tiuca N; Petrisor DC; Lenghel A; Santos J
United European Gastroenterol J; 2019 Oct; 7(8):1093-1101. PubMed ID: 31662866
[TBL] [Abstract][Full Text] [Related]
5. Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis.
Campolo M; Casili G; Paterniti I; Filippone A; Lanza M; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438777
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability.
Campolo M; Lanza M; Filippone A; Paterniti I; Casili G; Scuderi SA; Ardizzone A; Cuzzocrea S; Esposito E
Skin Pharmacol Physiol; 2020; 33(4):231-236. PubMed ID: 32846412
[TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
8. Correction: Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.
Petrisor DC; Etropolska Z; Elenski K; Dimitrova E; Santos J
Dig Dis Sci; 2024 May; 69(5):1897-1899. PubMed ID: 38564150
[No Abstract] [Full Text] [Related]
9. Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial.
Kaplan MA; Prior MJ; Ash RR; McKonly KI; Helzner EC; Nelson EB
Arch Fam Med; 1999; 8(3):243-8. PubMed ID: 10333820
[TBL] [Abstract][Full Text] [Related]
10. Topical Application of a Formulation Containing Pea Proteins and Xyloglucan in Adult Patients with Atopic Dermatitis: A Double-blind, Parallel, Randomized, Placebo-controlled, Multicenter Study.
Sowlati M; Orzan OA; Morariu SH; Etropolska Z; Veraldi S; Dimitrov S
J Clin Aesthet Dermatol; 2023 Jul; 16(7):35-41. PubMed ID: 37560506
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort.
Hanauer SB; DuPont HL; Cooper KM; Laudadio C
Curr Med Res Opin; 2007 May; 23(5):1033-43. PubMed ID: 17519069
[TBL] [Abstract][Full Text] [Related]
12. Xyloglucan galactosyl- and fucosyltransferase activities from pea epicotyl microsomes.
Faïk A; Chileshe C; Sterling J; Maclachlan G
Plant Physiol; 1997 May; 114(1):245-54. PubMed ID: 9159950
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Alterations and Small Intestinal Bacterial Overgrowth in Functional Abdominal Bloating/Distention.
Noh CK; Lee KJ
J Neurogastroenterol Motil; 2020 Sep; 26(4):539-549. PubMed ID: 32989189
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study.
Sowlati M; Morariu SH; Orzan O; Veraldi S; Dodiuk-Gad RP; Orasan RI; Gainaru C
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2669-2679. PubMed ID: 37740857
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial.
Schmulson MJ; Chiu-Ugalde J; Sáez-Ríos A; López-Colombo A; Mateos-Pérez GJ; Remes-Troche JM; Sobrino-Cossio S; Soto-Pérez JC; Tamayo de la Cuesta JL; Teramoto-Matsubara OT; López-Alvarenga JC
J Clin Gastroenterol; 2020 Apr; 54(4):e30-e39. PubMed ID: 31385885
[TBL] [Abstract][Full Text] [Related]
16. Xyloglucan sidechains modulate binding to cellulose during in vitro binding assays as predicted by conformational dynamics simulations.
Levy S; Maclachlan G; Staehelin LA
Plant J; 1997 Mar; 11(3):373-86. PubMed ID: 9107029
[TBL] [Abstract][Full Text] [Related]
17. Xyloglucan oligosaccharide alpha-L-fucosidase activity from growing pea stems and germinating nasturtium seeds.
Farkas V; Hanna R; Maclachlan G
Phytochemistry; 1991; 30(10):3203-7. PubMed ID: 1367786
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of xyloglucan by nasturtium seed xyloglucanase and transglycosylation to xyloglucan subunit oligosaccharides.
Farkas V; Sulova Z; Stratilova E; Hanna R; Maclachlan G
Arch Biochem Biophys; 1992 Nov; 298(2):365-70. PubMed ID: 1416968
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trial.
Ohkubo H; Kessoku T; Tanaka K; Takahashi K; Takatsu T; Yoshihara T; Misawa N; Ashikari K; Fuyuki A; Kato S; Higurashi T; Hosono K; Yoneda M; Misumi T; Shinoda S; Stanghellini V; Nakajima A
Biosci Microbiota Food Health; 2024; 43(2):135-144. PubMed ID: 38562545
[TBL] [Abstract][Full Text] [Related]
20. Effect of simethicone for the management of early abdominal distension after laparoscopic cholecystectomy: a multicenter retrospective propensity score matching study.
Zhu Y; Li J; Gao J; Bai D; Yu Z; Jin S; Chen J; Li S; Jiang P; Ge Z; Liu M; Sun C; Su Y; Zhang Y; Zhang Y
BMC Surg; 2024 May; 24(1):170. PubMed ID: 38811935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
